Practical Dermatology

12/03/2025

📢 NEW: A small proof-of-concept study indicates 80% of patients with moderate-to-severe hidradenitis suppurativa achieved HiSCR after 24 weeks on tirzepatide. Although early, the results suggest dual incretin therapy could offer a new treatment direction.

Read more ➡️ https://ow.ly/jkJj50XBAmU

12/02/2025

👀📰 FROM THE ISSUE: Can Prescription Hyperhidrosis Treatments Help Mitigate Symptoms? In the November/December issue of Practical Dermatology, contributor Graham Litchman, MD, tackles the question of whether prescription hyperhidrosis treatments mitigate symptoms.

✍️He writes: "Hyperhidrosis (HH) is more than a quality-of-life issue—it can significantly exacerbate dermatologic diseases including atopic dermatitis (AD), acne, psoriasis,rosacea, seborrheic dermatitis, cholinergic urticaria (CU), and hidradenitis suppurativa (HS). In patients with HH and one or more of these conditions, controlling excessive sweating may be an important adjunct to disease management."

Read the article ➡️ https://ow.ly/1gYo50XwH7H

Clinicians should begin to think beyond standard protocols and recognize sweat management as a potentially powerful tool in their therapeutic arsenal.

12/01/2025

🔬 🤖 MACHINE LEARNING MODEL IMPROVES ACCURACY: A newly developed 14-gene model powered by machine learning offers a new tool for personalized prognosis in melanoma that outperforms current models, new study results suggest. The signature also highlights CUL2 as a key tumor suppressor. 👨‍⚕️🔎

Read more ➡️ https://ow.ly/E0Nw50XwH4f

11/29/2025

👩‍⚕️ 🙋‍♀️🙋‍♂️ASK ME ANYTHING MENTORSHIP SESSION: Sheila Barbarino, MD, FACS, provides insights on her career, her success using social media as a marketing tool for her practice, critical practice management issues, and much more.

📺 Watch here ➡️ https://ow.ly/atZI50XwqTh

Sheila Barbarino, MD, FACS, discusses the keys to her success using social media as a marketing tool for her practice, critical practice management...

11/28/2025

🆕 👩‍🔬 WHAT'S NEW IN DEVICES AND ADAPTOGENS: Jacqueline Watchmaker, MD, explores the intersection of medical devices and adaptogenic therapies in skincare. This video was recorded at the Science of Skin Summit in Austin, TX.

📺 Watch here ➡️ https://ow.ly/Mmge50Xwiw0

Jacqueline Watchmaker, MD, explores the intersection of medical devices and adaptogenic therapies in skincare. This video was recorded at the...

11/27/2025

💇‍♀️🧴 WHERE HAIR AND SKIN CARE MEET: Iris Rubin, MD, FAAD, discusses integrative approaches at the intersection of hair care and skin care. This video was recorded at the Science of Skin Summit in Austin, TX. 🩺 👩‍⚕️

📺 Watch here ➡️ https://ow.ly/rUgb50XwiqO

Iris Rubin, MD, FAAD, discusses integrative approaches at the intersection of hair care and skin care. This video was recorded at the Science of...

11/26/2025

🏃💼 ⚖️ BALANCING A BUSY CAREER: Peter A. Lio, MD, a Clinical Assistant Professor of Dermatology & Pediatrics at Northwestern University Feinberg School of Medicine, discusses how he balances his clinical practice with his academic responsibilities, thought leadership, and more in this "Ask Me Anything" mentorship session.

Watch here ➡️ https://ow.ly/zhNC50XwinN

Peter A. Lio, MD, a Clinical Assistant Professor of Dermatology & Pediatrics at Northwestern University Feinberg School of Medicine, discusses...

11/25/2025

📣 🆕 NEW ISSUE ALERT: The November/December issue of Practical Dermatology spotlights GLP-1 Receptor Agonists (GLP-1RAs) and their potential dermatologic and aesthetic applications. Under the guidance of Guest Editor Ted Lain, MD, experts take a comprehensive look from several angles at how these life-changing medications are being studied and applied in dermatology.🩺✨

📚 Featured articles include:
• The Role of GLP-1RAs in Inflammatory Derm – Dr. Michael Payette
• GLP-1RAs and the Aesthetic Patient – Dr. Ardalan Minokadeh
• Pipeline and Potential Roles in Dermatology – Dr. Corey Snyder et al
• Plus More!

Additional highlights:
• Early-use moisturizer in AD prevention
• Managing and screening for hyperhidrosis in pediatric and adult patients
• Practice tips to enhance your digital presence

Read the issue here ➡️ https://ow.ly/n1hm50Xwims

None

11/24/2025

🎙️👨‍⚕️NEW PRACTICAL DERMATOLOGY PODCAST: In the latest episode of the Practical Dermatology Podcast, International Federation of Psoriasis Associations (IFPA) executive director Frida Dunger discusses recent awareness efforts, and Practical Dermatology chief medical editor Neal Bhatia, MD, FAAD, is joined by editorial board member Brad P. Glick, DO, MPH, FAAD, for an honest discussion about the state of dermatology residencies. 🔈🩺

Listen here ➡️ https://ow.ly/Ltow50XwhXu

International Federation of Psoriasis Associations (IFPA) executive director Frida Dunger discusses recent awareness efforts, and Practical...

11/22/2025

👩‍⚕️🙋‍♂️🙋‍♀️'ASK ME ANYTHING' MENTORSHIP SESSION: Natasha Atanaskova Mesinkovsa, MD, PhD, vice chair for clinical research in the UC Irvine School of Medicine's Department of Dermatology, discusses how she navigated her unique career path, how she balances her various responsibilities now, and more in this YoungMD Connect "Ask Me Anything" mentorship session.

Watch here ➡️ https://ow.ly/RoC450XwhYh

Natasha Atanaskova Mesinkovsa, MD, PhD, vice chair for clinical research in the UC Irvine School of Medicine's Department of Dermatology, discusses...

11/21/2025

📢 💊 🩺 ORAL MINOXODIL FOR FPHL: Veradermics recently announced the launched the first phase 2/3 clinical trial of an oral treatment for female pattern hair loss (FPHL) with its novel formulation, VDPHL01. Final phase 2 results in both men and women are
expected in 2026.

Read more ➡️ https://ow.ly/1JGx50XuSJT

11/20/2025

🔎 💵 FOLLOWING THE MONEY: A new analysis of National Institutes of Health (NIH) vitiligo funding shows an upward trend, support from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), and a focus on pathophysiology and treatment development. Medical schools received the most awards.🏅🩺

Read more ➡️ https://ow.ly/ErZT50XuWn8

Funding trends National Institutes of Health (NIH) funding trends shows steady, long-term support for vitiligo research from 1985 through 2024,...